- Home
- ARAY vs BWAY Comparison
ARAY vs BWAY Comparison
Compare ARAY & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- BWAY
- Stock Information
- Founded
- ARAY 1990
- BWAY 2003
- Country
- ARAY United States
- BWAY Israel
- Employees
- ARAY N/A
- BWAY N/A
- Industry
- ARAY Medical/Dental Instruments
- BWAY Medical/Dental Instruments
- Sector
- ARAY Health Care
- BWAY Health Care
- Exchange
- ARAY Nasdaq
- BWAY Nasdaq
- Market Cap
- ARAY 171.0M
- BWAY 159.3M
- IPO Year
- ARAY 2007
- BWAY 2019
- Fundamental
- Price
- ARAY $1.70
- BWAY $9.12
- Analyst Decision
- ARAY Strong Buy
- BWAY Buy
- Analyst Count
- ARAY 1
- BWAY 4
- Target Price
- ARAY $9.00
- BWAY $13.17
- AVG Volume (30 Days)
- ARAY 646.4K
- BWAY 86.3K
- Earning Date
- ARAY 11-06-2024
- BWAY 11-12-2024
- Dividend Yield
- ARAY N/A
- BWAY N/A
- EPS Growth
- ARAY N/A
- BWAY N/A
- EPS
- ARAY N/A
- BWAY 0.04
- Revenue
- ARAY $444,204,000.00
- BWAY $38,631,000.00
- Revenue This Year
- ARAY $6.33
- BWAY $378.91
- Revenue Next Year
- ARAY $5.60
- BWAY $20.27
- P/E Ratio
- ARAY N/A
- BWAY $117.82
- Revenue Growth
- ARAY N/A
- BWAY 34.19
- 52 Week Low
- ARAY $1.40
- BWAY $4.56
- 52 Week High
- ARAY $3.05
- BWAY $10.98
- Technical
- Relative Strength Index (RSI)
- ARAY 40.89
- BWAY 41.64
- Support Level
- ARAY $1.81
- BWAY $8.96
- Resistance Level
- ARAY $2.15
- BWAY $10.98
- Average True Range (ATR)
- ARAY 0.13
- BWAY 0.57
- MACD
- ARAY -0.02
- BWAY -0.18
- Stochastic Oscillator
- ARAY 0.00
- BWAY 19.83
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.